A cohort event monitoring study to characterise use of eplontersen in patients with prior liver transplant and pre-existing severe hepatic impairment and to assess long-term safety among all new users of eplontersen (sTTRing)

Documents

Study protocol

Initial protocol

D8450R00022 - Protocol 2.0 Final_redacted.pdf

Study results

Study report

Other information

Study, other information

https://www.clinicaltrials.gov/study/NCT06465810?term=EPLONTERSEN&rank=8